List view / Grid view
University of Dundee
Almirall announces a new research collaboration with the University of Dundee to develop an innovative treatment for skin diseases
Almirall and University of Dundee announce a collaboration to develop a novel treatment to fully control itch in skin diseases and achieve a prolonged and profound therapeutic effect for patients.
Researchers used an experimental small molecule that helped restore the removal of damaged mitochondria from brain cells in a mouse model of Parkinson's.
Drug analysis at the Francis Crick Institute and University of Dundee has revealed 15 potential antivirals that could lead to new COVID-19 treatments.
LifeArc and the Medical Research Council have funded a new drug screening facility that will be established to accelerate COVID-19 drug discovery.
UKRI will provide £4 million in funding to establish a data infrastructure for scientists in the UK to study antibodies from COVID-19 patient samples.
Researchers have found that CBD induces an enzyme with antioxidant and anti-inflammatory properties in the top layer of the skin.
The UK government will invest £8.4 million in COVID-19 research projects to reveal more information that can be used to develop therapies and vaccines against the disease.
Researchers have discovered an enzyme that blocks a genetic pathway that causes Parkinson’s, which could be used as a treatment in the future.
Scientists use data from human cancers and C. elegans to understand mutational causes of cancer...
Scientists have discovered that itaconate - a molecule derived from glucose - acts as a powerful off-switch for macrophages...
4 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Researchers used pioneering techniques to develop a `small molecule’ chemical probe which offers highly targeted access to the hypoxic signalling pathway...
3 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Bicyclic nitro-drugs used in the treatment of tuberculosis, including the recently approved drug delamanid, were reported as promising fast track options...
29 July 2016 | By Mandy Parrett, Editorial Assistant
Scientists have developed a new method of measuring the activity of disease-causing mutations in the LRRK2 gene, a major cause of inherited Parkinson’s disease.